The BMJ Today: The FDA, drug addicts, and standing with junior doctors

• The FDA’s new clothes Two new research papers (here and here) and a linked editorial take a detailed look at the FDA’s regulatory process. They present concerns that the FDA has prioritised expedited approvals at the expense of adequately assessing whether new drugs are more effective than existing products or whether they are safe. […]

Read More…

Oommen C. Kurian: Dengue in Delhi—fighting an outbreak with the wrong numbers and an unwilling private sector

The current dengue outbreak in Delhi came to international prominence following the unfortunate incident of a young couple who committed suicide after their son was rejected treatment by many prominent private sector hospitals in Delhi. Treatment was denied despite the government saying on 28 August that patients should not be denied admission to hospital on […]

Read More…

#imajuniordoctor: Junior doctors respond to the new junior doctor contract on social media

An online petition has already collected over 50,000 signatures calling for the BMA to support doctors taking strike action against the planned introduction of new junior doctor contracts. Doctors are concerned that a recent government decision to impose new junior doctor contracts will result in lower pay and increased hours. This has been met with huge […]

Read More…

Carl Heneghan: 329 trial restoration highlights need to restore public trust in trials

Fourteen years after a drug trial had been published, investigators —using multiple sources, including regulatory and legal documents—restored a version of the same trial and came to completely opposite conclusions. The original study of 275 adolescents with depression—Study 329—concluded “paroxetine is generally well tolerated and effective for major depression in adolescents.” Yet the 2015 reanalysis […]

Read More…

Desmond O’Neill: Nordic insights into the art of ageing and dying well

I hate to miss the opening ceremonies of European geriatric medicine conferences, with the individual interplay between this most complex of medical specialties with the national characteristics of the host nation. Norway is notable for its ability to fuse simplicity and sophistication, typified by the striking new Opera House in Oslo where the sloping roof provides […]

Read More…